ARCHIVES

NIH Selects 16 Clinical Centers for Women’s Health Initiative

This article is from The Cancer Letter archive.

Vol. 19 No. 15 | April 9, 1993

Download PDF Visit The Full Archive

Related Articles

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

Management Survey Finds Problems At ACS, Advises Change

July 3, 1992

Text of concept statement included in this 8-page issue.

July 16, 2004

Porter Softens Proposal To require SBIR Scores To Match R01s

July 26, 1996

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

Six Panels To Help NCI Identify Progress; NCINews Roundup

January 8, 1993